These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 10652178

  • 1. Mutual interactions between DTaP-IPV and Haemophilus influenzae type b (Hib)-conjugated vaccines in laboratory animal models.
    Shams H, Heron I.
    Biologicals; 1999 Sep; 27(3):227-40. PubMed ID: 10652178
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine.
    Gupta RK, Anderson R, Cecchini D, Rost B, Xu J, Gendreau K, Saroff DL, Marchant C, Siber GR.
    Biologicals; 1999 Jun; 27(2):167-76. PubMed ID: 10600208
    [Abstract] [Full Text] [Related]

  • 3. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine.
    Tejedor JC, Moro M, Ruiz-Contreras J, Castro J, Gómez-Campderá JA, Navarro ML, Merino JM, Martín-Ancel A, Roca J, García-del-Río M, Jurado A, Díez-Delgado FJ, Omeñaca F, García-Sicilia J, Boceta R, García-Corbeira P, Jacquet JM, Collard A, Schuerman L, Spanish DTaP-HBV-IPV-097 Study Group.
    Pediatr Infect Dis J; 2006 Aug; 25(8):713-20. PubMed ID: 16874171
    [Abstract] [Full Text] [Related]

  • 4. Development of a guinea-pig model for potency/immunogenicity evaluation of diphtheria, tetanus acellular pertussis (DTaP) and Haemophilus influenzae type b polysaccharide conjugate vaccines.
    Gupta RK, Anderson R, Cecchini D, Rost B, Griffin P, Benscoter K, Xu J, Montanez-Ortiz L, Siber GR.
    Dev Biol Stand; 1996 Aug; 86():283-96. PubMed ID: 8785957
    [Abstract] [Full Text] [Related]

  • 5. Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat model.
    Mawas F, Newman G, Burns S, Corbel MJ.
    J Infect Dis; 2005 Jan 01; 191(1):58-64. PubMed ID: 15593004
    [Abstract] [Full Text] [Related]

  • 6. A fully liquid diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis--Haemophilus influenzae type b conjugate vaccine: immunogenicity and safety of primary vaccination in Taiwanese infants.
    Lin TY, Wang YH, Chang LY, Huang YC, Kao HT, Lin PY, Lu HK, Chavand P, Ortiz E.
    Int J Infect Dis; 2007 Mar 01; 11(2):129-36. PubMed ID: 16762579
    [Abstract] [Full Text] [Related]

  • 7. Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial.
    Guerra FA, Blatter MM, Greenberg DP, Pichichero M, Noriega FR, Pentacel Study Group.
    Pediatrics; 2009 Jan 01; 123(1):301-12. PubMed ID: 19117896
    [Abstract] [Full Text] [Related]

  • 8. New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel).
    Johns TL, Hutter GE.
    Ann Pharmacother; 2010 Mar 01; 44(3):515-23. PubMed ID: 20197476
    [Abstract] [Full Text] [Related]

  • 9. The effect of conjugation on immunogenicity and potency of protein carriers of polyribosylribitol phosphate (PRP) conjugated vaccines in the mouse model.
    Shams H, Heron I.
    APMIS; 1998 May 01; 106(5):526-34. PubMed ID: 9674889
    [Abstract] [Full Text] [Related]

  • 10. Combination of DTP and Haemophilus influenzae type b conjugate vaccines can affect laboratory evaluation of potency and immunogenicity.
    Redhead K, Sesardic D, Yost SE, Attwell AM, Watkins J, Hoy CS, Plumb JE, Corbel MJ.
    Biologicals; 1994 Dec 01; 22(4):339-45. PubMed ID: 7779360
    [Abstract] [Full Text] [Related]

  • 11. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
    Pichichero ME, Bernstein H, Blatter MM, Schuerman L, Cheuvart B, Holmes SJ, 085 Study Investigators.
    J Pediatr; 2007 Jul 01; 151(1):43-9, 49.e1-2. PubMed ID: 17586189
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine.
    Cheng HK, Rajadurai VS, Amin Z, Sriram B, Yee MF, Han HH, Bock HL, Safary A.
    Southeast Asian J Trop Med Public Health; 2004 Sep 01; 35(3):685-92. PubMed ID: 15689088
    [Abstract] [Full Text] [Related]

  • 13. Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections.
    Schmitt HJ, Knuf M, Ortiz E, Sänger R, Uwamwezi MC, Kaufhold A.
    J Pediatr; 2000 Sep 01; 137(3):304-12. PubMed ID: 10969252
    [Abstract] [Full Text] [Related]

  • 14. Safety and immunogenicity of a DTaP-IPV(Vero) (serum-free) combination vaccine in comparison to DTaP-IPV(Mkc) when administered simultaneously with Haemophilus influenzae type B conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age.
    Pietrzyk JJ, Wysocki J, Pejcz J, Galaj A, Majda-Stanislawska E, Käyhty H, Thierry-Carstensen B, Jensen AM.
    Vaccine; 2008 Sep 26; 26(41):5296-303. PubMed ID: 18675870
    [Abstract] [Full Text] [Related]

  • 15. Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age.
    Halperin SA, Tapiero B, Diaz-Mitoma F, Law BJ, Hoffenbach A, Zappacosta PS, Radley D, McCarson BJ, Martin JC, Brackett LE, Boslego JW, Hesley TM, Bhuyan PK, Silber JL.
    Vaccine; 2009 Apr 28; 27(19):2540-7. PubMed ID: 19124057
    [Abstract] [Full Text] [Related]

  • 16. Immunogenicity and reactogenicity of a three-dose primary vaccination course with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-haemophilus influenzae type b vaccine coadministered with a meningococcal C conjugate vaccine.
    Tejedor JC, Omeñaca F, García-Sicilia J, Verdaguer J, Van Esso D, Esporrín C, Molina V, Muro M, Marés J, Enrubia M, Moraga F, García-Corbeira P, Dobbelaere K, Schuerman L, Spanish DTPa-HBV-IPV/Hib-076 Study Group.
    Pediatr Infect Dis J; 2004 Dec 28; 23(12):1109-15. PubMed ID: 15626947
    [Abstract] [Full Text] [Related]

  • 17. The immunological response of Thai infants to haemophilus influenzae type B polysaccharide-tetanus conjugate vaccine co-administered in the same syringe with locally produced diphtheria-tetanus-pertussis vaccine.
    Kerdpanich A, Hutagalung Y, Watanaveeradej V, Bock HL, Steinhoffmd M.
    J Med Assoc Thai; 2007 Jul 28; 90(7):1330-6. PubMed ID: 17710973
    [Abstract] [Full Text] [Related]

  • 18. Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: safety, immunogenicity and persistence of antibody responses.
    Heininger U, DTP-HBV-IPV-059 Study Group, DTP-HBV-IPV-096 Study Group, Sänger R, Jacquet JM, Schuerman L.
    Vaccine; 2007 Jan 22; 25(6):1055-63. PubMed ID: 17049692
    [Abstract] [Full Text] [Related]

  • 19. Immunogenicity and reactogenicity of a booster dose of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine given to toddlers of 13-14 months of age with antibody persistence up to 31 months of age.
    Tejedor JC, Moro M, Merino JM, Gómez-Campderá JA, García-del-Rio M, Jurado A, Díez-Delgado FJ, Omeñaca F, García-Sicilia J, Ruiz-Contreras J, Martin-Ancel A, Roca J, Boceta R, García-Corbeira P, Maechler G, Boutriau D, Spanish 102547 Study Group.
    Pediatr Infect Dis J; 2008 Jul 22; 27(7):579-88. PubMed ID: 18536619
    [Abstract] [Full Text] [Related]

  • 20. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).
    Knuf M, Szenborn L, Moro M, Petit C, Bermal N, Bernard L, Dieussaert I, Schuerman L.
    Pediatr Infect Dis J; 2009 Apr 22; 28(4 Suppl):S97-S108. PubMed ID: 19325452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.